2-Propen-1-one, 1-[4-[8-[[3-methyl-4-[(1-methyl-1H-benzimidazol-5-yl)oxy]phenyl]amino]pyrimido[5,4-d]pyrimidin-2-yl]-1-piperazinyl]-

Chemical Properties

Boiling point	784.9±70.0 °C(Predicted)
Density	1.39±0.1 g/cm3(Predicted)
pka	5.24±0.10(Predicted)
form	Solid
color	Light yellow to yellow
InChIKey	JKBYBPNRTMHEGS-UHFFFAOYSA-N
SMILES	C(N1CCN(C2=NC=C3N=CN=C(NC4=CC=C(OC5=CC=C6N(C)C=NC6=C5)C(C)=C4)C3=N2)CC1)(=O)C=C

Send Inquriy

Animal Model:	NMRI-Foxn1nu mice, PC-9 HER2^YVMA xenograft model^[1]
Dosage:	3, 10, 30 and 100 mg/kg
Administration:	Oral administration, twice per day for 40 days
Result:	Resulted in tumor regressions in a dose-dependent manner (113%, 126%, 153% and 166% tumor growth inhibition at 3, 10, 30 and 100 mg/kg, respectively).